Drug intelligence / Profile preview

Qijiao Shengbai Jiaonang

Development stage
Unknown
Lead developer
Guiyang Dechangxiang Pharmaceutical
Administration
Oral
01

Overview

Qijiao Shengbai Jiaonang (also known as Qijiao Shengbai Capsule) is a traditional Chinese medicine formulation derived from Miao nationality medicine, clinically utilized for the treatment and prophylaxis of leukopenia, particularly chemotherapy-induced or radiotherapy-induced leukopenia and bone marrow suppression. The formulation is a complex herbal mixture composed of seven active ingredients: *Indigofera stachyoides* Lindl. (Xue Renshen), *Astragalus membranaceus* (Huang Qi), *Equus asinus* L. (E'jiao/donkey-hide gelatin), *Angelica sinensis* (Dang Gui), *Ziziphus jujuba* Mill. (Da Zao), *Sophora flavescens* Ait. (Ku Shen), and *Epimedium brevicornu* Maxim. (Yin Yanghuo). It functions to nourish Qi and blood while enhancing immune function. Key bioactive components include genistein, quercetin, caffeic acid, and ferulic acid. Mechanistically, Qijiao Shengbai Jiaonang acts via multiple pathways, including the PI3K-Akt-mTOR/FoxO3a signaling axis, the leukotriene pathway (targeting ALOX5), and the Bcl2/Bax/CASPASE3 apoptotic pathway, to stimulate white blood cell production and protect bone marrow function.

Brand names
DechangxiangHanfang
Other names
芪胶升白胶囊Qijiao Shengbai CapsuleQJSBQJSBC
02

Targets

PTPN11 (Tyrosine-protein phosphatase non-receptor type 11)BAX (Apoptosis regulator BAX)CASP3 (Caspase-3)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on Qijiao Shengbai Jiaonang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qijiao Shengbai Jiaonang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call